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Abstract
Background: Chromatin immunoprecipitation (ChIP) assays coupled to genome arrays (Chip-on-
chip) or massive parallel sequencing (ChIP-seq) lead to the genome wide identification of binding
sites of chromatin associated proteins. However, the highly variable quality of antibodies and the
availability of epitopes in crosslinked chromatin can compromise genomic ChIP outcomes. Epitope
tags have often been used as more reliable alternatives. In addition, we have employed protein in
vivo biotinylation tagging as a very high affinity alternative to antibodies. In this paper we describe
the optimization of biotinylation tagging for ChIP and its coupling to a known epitope tag in
providing a reliable and efficient alternative to antibodies.
Results: Using the biotin tagged erythroid transcription factor GATA-1 as example, we describe
several optimization steps for the application of the high affinity biotin streptavidin system in ChIP.
We find that the omission of SDS during sonication, the use of fish skin gelatin as blocking agent
and choice of streptavidin beads can lead to significantly improved ChIP enrichments and lower
background compared to antibodies. We also show that the V5 epitope tag performs equally well
under the conditions worked out for streptavidin ChIP and that it may suffer less from the effects
of formaldehyde crosslinking.
Conclusion: The combined use of the very high affinity biotin tag with the less sensitive to
crosslinking V5 tag provides for a flexible ChIP platform with potential implications in ChIP
sequencing outcomes.
Background
Affinity tags have been widely used for the study of pro-
tein interactions and the isolation of protein complexes.
Such tags are also increasingly used in ChIP assays in
detecting the in vivo binding of transcription factors and
associated co-factors to their target genes in chromatin. In
searching for the optimal affinity tag for ChIP applica-
tions, three criteria are important: (a) tags must have high
binding affinity; (b) tags should be preferably small and
not strongly charged so as to minimize possible interfer-
ence with transcription factor function (c) tags should be
fairly insensitive to formaldehyde fixation. The latter is
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or histidine residues [1-3].
The biotin/(strept)avidin affinity system fulfils the above
criteria due to its unique characteristics [4], which
include: (a) the very tight and specific binding of biotin by
avidin (or streptavidin) which, with a Kd of 1015 L*mol -1,
is one of the highest non covalent interactions known in
nature, close to almost 103 – 106times greater than the
interaction of epitopes with their specific antibodies.
Once formed, the biotin-streptavidin complex is not dis-
turbed by changes in pH, introduction of detergents or
high salt concentration, thus remaining stable even under
very stringent washing conditions; (b) biotin is a very
small molecule and is not known to affect the biological
activity of tagged proteins [5,6]; (c) there are few (mostly
cytoplasmic) naturally biotinylated proteins in mamma-
lian cells, as a result the non-specific background binding
of nuclear extract is low [7].
We have previously used [7,8] a short (23aa) biotinylata-
ble tag [9,10] for the purification of GATA-1 protein com-
plexes from nuclear extracts of erythroid cells. GATA-1 is a
DNA sequence-specific zinc finger transcription factor
that is essential for the differentiation of erythroid, meg-
akaryocytic, eosinophil and mast cell lineages [11,12]. N-
terminally tagged GATA-1 was co-expressed with the E.
coli BirA biotin ligase in mouse erythroleukemic (MEL)
cells and subsequently purified from nuclear extracts
together with interacting proteins by high affinity binding
to streptavidin beads [7]. In this way, a number of known
and novel GATA-1 protein partners were identified [8].
We also tested the utility of the biotin tag and streptavidin
binding in ChIP assays and provided preliminary evi-
dence that it can be successfully applied in place of anti-
bodies in ChIPs of GATA-1 target genes [7,13].
Subsequent work in other labs has provided further sup-
porting evidence for the application of biotinylation tag-
ging in ChIP and Chip-on-chip assays [14-16]. Thus,
despite the fact that biotin contains groups that are
crosslinkable by formaldehyde, it can be successfully
employed in ChIP assays
In this manuscript we present steps for improving the effi-
ciency of biotinylation tagging in ChIP applications, using
biotin-tagged GATA-1 in combination with known target
genes [8] as an example. We first show that different
streptavidin beads are not equally efficient in ChIP assays.
We also show that effective blocking with fish skin gelatin
and omission of SDS during chromatin sonication are
important factors in reducing background signals, which
is a major concern in ChIP using complex chromatin from
mammalian cells. Furthermore, we explored the utility of
double affinity tags in ChIP assays. Different tags may be
used in tandem, separated by a protease cleavage site to
allow for differential purification using either tag or for
two sequential affinity purification steps using both tags
to lower the background of non-specific proteins. At the
same time, this approach can greatly enhance the ability
to purify the complexes to homogeneity (by using several
factors of the same complex differentially tagged and co-
expressed) for other applications. To these ends, we com-
bined the biotin tag with the V5 tag and show that the V5
tag antibody mediated ChIP is as efficient as the biotin
streptavidin ChIP. These results have important implica-
tions when it comes to selecting an optimal strategy for
genomic ChIP and proteomic analyses of transcription
factor functions.
Results
We previously showed using biotin-tagged GATA-1 that
streptavidin binding of crosslinked chromatin can substi-
tute for antibodies in enriching for GATA-1 target genes in
ChIP assays [7]. Due to the potential advantages offered
by the very high affinity of streptavidin for binding to
biotin and the importance of having multiple tags that
can be used in the same cell, we wanted to extend these
observations in developing an optimized protocol for the
streptavidin binding of chromatin from cells expressing
biotin-tagged GATA-1. In doing so, we used the EKLF and
c-myb promoters as examples of GATA-1 gene targets that
are upregulated or repressed, respectively, in erythroid
cells. Figure 1A (EKLF) and Additional File 1A (myb)
show the location of primers used for the EKLF and myb
promoters and negative control sequences. Primer
sequences are listed in Table 1.
Comparison of different types of streptavidin beads
Biotinylation of biological substrates is frequently used in
a variety of different applications and hence many manu-
facturers offer a wide range of immobilized streptavidin
matrices. We have previously used paramagnetic M280
streptavidin Dynabeads for the isolation of protein com-
plexes [7,8,17-19]. We also tested the performance of
M280 beads in chromatin immunoprecipitations and
compared them to three other available matrices: strepta-
vidin agarose, streptavidin mutein and NeutrAvidin.
Streptavidin agarose was used to test whether an immobi-
lization matrix different to that of paramagnetic particles
would give better yields. NeutrAvidin is a streptavidin
derivative without carbohydrate side chains which is pre-
dicted to reduce background binding. Streptavidin mutein
is a mutated recombinant streptavidin which binds biotin
with a lower affinity thus allowing elution of bound mate-
rial under gentler conditions by using biotin. Chromatin
from biotin-tagged GATA-1 cells and control cells express-
ing BirA ligase only, was bound to different types of beads
under identical conditions (overnight binding and subse-
quent washes). Biotin-tagged GATA-1 was eluted from the
beads by decrosslinking, except for the mutein beadsPage 2 of 14
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A) Location of the ChIP primers in the EKLF geneFigure 1
A) Location of the ChIP primers in the EKLF gene. "GATA" boxes indicate GATA-1 binding sites. B) Comparison of dif-
ferent derivatives of immobilized streptavidin: NeutrAvidin, streptavidin agarose, streptavidin mutein and M280 Dynabeads. 
Relative enrichment for EKLF sequences was calculated over negative control chromatin isolated from cells expressing BirA 
biotin ligase, but not tagged GATA-1.
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BMC Molecular Biology 2009, 10:6 http://www.biomedcentral.com/1471-2199/10/6where we used biotin for elution. We find that the M280
streptavidin Dynabeads are the most efficient in capturing
biotin-tagged GATA-1 bound to the EKLF (Figure 1B) and
myb (Additional File 1B) promoters. Using M280 beads,
we also find clear enrichment of GATA-1 binding to regu-
latory elements of the repressed GATA-2 locus (Additional
File 2B). As a result, the M280 Dynabeads were used in all
subsequent experiments.
Pre-clearing chromatin
Pre-clearing of chromatin is one of the methods used to
decrease background binding in ChIP assays using anti-
bodies. We tested this by preclearing chromatin with Pro-
tein G paramagnetic beads (Dynal) for 1 hour at 4°C. As
shown in Figure 2, this resulted in lower background and
improved enrichment of EKLF sequences bound by biotin
tagged GATA-1. Similar results were also obtained with
the c-myb promoter (Additional File 1C).
Blocking with fish skin gelatin
Among various blocking compounds (e.g. BSA, Chicken
Egg Albumin etc.) fish skin gelatin (FGEL) has been
shown to be very effective for blocking in Western and
ELISA experiments [20,21]. In addition, FGEL is a very
inexpensive reagent compared to other blocking reagents
such as BSA. We therefore investigated whether the use of
FGEL for blocking would improve the performance of
M280 beads in a streptavidin ChIP. Figure 3 shows that
addition of as little as 0.5% (final concentration) of FGEL
(together with salmon sperm DNA) can significantly
improve the yield of EKLF target sequences bound by
GATA-1. Similar results were also observed with the c-myb
promoter and GATA-2 locus sequences (Additional Files
1C and 2, respectively). Thus, blocking the beads for 1
hour with FGEL and salmon sperm DNA reduces the
background compared to blocking with salmon sperm
DNA alone. In addition to blocking the beads, we also
added 1% FGEL to chromatin during binding to the beads
and obtained similar results to those when FGEL was used
for blocking the beads only (not shown). As a result, we
have included 1% FGEL in blocking the beads in all sub-
sequent experiments.
It has been shown previously that biotin tagging allows
more stringent washes (containing up to 3% SDS) com-
pared to other affinity tags [15]. For example, urea and
thiourea are reagents widely used in proteomics to resus-
pend hydrophobic proteins. We therefore tested whether
the background binding of hydrophobic proteins can be
reduced by washing in urea/thiourea/SDS. We found that
the additional wash did not significantly lower the back-
ground or increase the specific binding signals of the EKLF
or c-myb promoters (data not shown) and this parameter
was not investigated further.
The non-covalent binding of biotin to streptavidin is one
of the strongest known in nature [22,23]. However this
presents a drawback when eluting bound chromatin from
the beads as is usually done in ChIP using antibodies. We
were indeed unsuccessful in eluting the biotinylated pro-
tein from the streptavidin beads. The only way it could be
removed was by boiling, which may result in some back-
ground due to the co-elution of non-specifically bound
proteins. Alternatives would be the inclusion of protease
(TEV or PreScission) cleavage sites [24-27], or the use of
double tags (see below).
Sonication without SDS
Most ChIP protocols, including those used in our labora-
tory, are based on the Upstate (now Millipore) ChIP pro-
tocol which includes sonicating chromatin in a buffer
containing 1% SDS. Addition of SDS introduces stringent
conditions and helps prevent the aggregation of insoluble
protein complexes. However, high SDS concentration
may affect optimal binding of chromatin by the antibody
or beads and, in some approaches, inclusion of SDS is not
compatible with further experimental procedures, for
example in chromatin fractionation by CsCl gradient cen-
trifugation [28,29].
Table 1: 
Primer name Sequence
Myb prom FOR ACTGCAGGGGCGCCAGATTT
Myb prom REV GGAGAAAGGGGAGGAGAAGGAGGTA
Neg myb FOR GAAGTAGAGGCAGGATAATCAGGAA
Neg myb REV AGGATGAACCAGGGCTAATGC
EKLF Upstream FOR CTGGCCCCCCTACCTGAT
EKLF Upstream REV GGCTCCCTTTCAGGCATTATC
EKLF Promoter FOR TATCGCACACACCCCTCCTT
EKLF Promoter REV CCCACATCTGATTGGCTGTCT
Neg EKLF FOR TGCTCCCCACTATGATAATGGA
Neg EKLF REV GCCACAACCAAAGAAGACATTTT
Necdin FOR GGTCCTGCTCTGATCCGAAG
Necdin REV GGGTCGCTCAGGTCCTTACTT
Amylase FOR CTCCTTGTACGGGTTGGT
Amylase REV AATGATGTGCACAGCTGAAPage 4 of 14
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Preclearing chromatin with Protein G DynabeadsFigure 2
Preclearing chromatin with Protein G Dynabeads. A) Relative enrichment of EKLF sequences calculated over chroma-
tin from control cells. The enrichment of the specific EKLF promoter elements appears lower after preclearing presumably due 
to some loss of chromatin in the additional preclearing step. B) Relative enrichment of biotin-tagged GATA-1 binding at EKLF 
promoter and enhancer calculated over the negative control sequence for biotin-tagged GATA-1 chromatin and chromatin 
from BirA expressing cells as negative control.
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BMC Molecular Biology 2009, 10:6 http://www.biomedcentral.com/1471-2199/10/6We therefore tested whether sonicating chromatin with-
out SDS would improve the efficiency of a streptavidin
ChIP. Omission of SDS did not affect the efficiency of
DNA shearing. Sonicating chromatin without SDS
resulted in higher enrichment of the EKLF (Figure 4) and
c-myb (Additional File 1D) promoter sequences, albeit
with a small increase in the background binding of the
EKLF negative control sequence. Thus, omitting SDS from
the sonication buffer improves the yield of a streptavidin
pull-down significantly. We next tested whether the omis-
sion of SDS would also improve a ChIP in a regular anti-
body precipitation. For this purpose we tested the
precipitation of a RAD21 gene target which, under the
standard SDS conditions, can be enriched 4–5 fold over
background. This represents a borderline enrichment for
further analysis by ChIP-sequencing (SK unpublished).
When a RAD21 ChIP to a site in the β globin locus in I/11
erythroid cells was carried out with or without SDS, the
sample without SDS gave a considerable improvement in
enrichment (Figure 5).
Comparison of biotin and V5 epitope tags to anti GATA-1 
N6 and M20 antibodies
The experiments described above were carried out with an
N-terminally biotin-tagged GATA-1 [7]. We also generated
a second construct containing a tandem affinity tag cre-
ated by fusing the short (14 aa) biotin tag [10] with the
14aa V5 tag to the C-terminus of GATA-1 (Figure 6A). V5
is a short peptide sequence derived from the C-terminus
of the P and V proteins of Simian virus 5 [30,31]. This con-
struct can be used in the two-step affinity purification of
tagged protein complexes, thus reducing background
binding. Alternatively, one of the tags can be used on its
own in cases where the second tag is inefficient, for exam-
ple due to reduced accessibility in crosslinked chromatin.
These are important considerations in ChIP experiments
particularly in applications involving ChIP-on-chip or
The effect of using different concentrations of FGEL in blocking the beadsFigure 3
The effect of using different concentrations of FGEL in blocking the beads. Relative enrichment was calculated for 
EKLF sequences over chromatin from non transfected control cells. Low enrichment of the EKLF promoter and enhancer 
sequences is observed when blocking with salmon sperm DNA alone (minus FGEL control) due to the high background binding 
obtained with chromatin from the non-transfected control cells.
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with the streptavidin-ChIP results obtained with the
biotin tag fused to the N-terminus of GATA-1.
We obtained a MEL stable transfectant expressing GATA-
1-V5-bio at approximately equal levels to the endogenous
GATA-1 protein (Figure 6B). We compared the efficiency
of ChIP by streptavidin binding or V5 antibody immuno-
precipitation to two anti-GATA-1 antibodies: the N6 rat
monoclonal antibody against the N-terminus of GATA-1
and the M20 goat polyclonal antibody against the C-ter-
minus of GATA-1. We find that both the streptavidin pull-
down with M280 Dynabeads and the ChIP with V5 anti-
bodies are at least as good as or more efficient in enriching
for EKLF sequences compared to the anti-GATA-1 N6 and
M20 antibodies, when compared to IgG controls or chro-
matin from cells expressing BirA only (Figure 6C and 6D).
The V5-ChIP also works very efficiently, as it gives 12-fold
higher enrichment in specific binding to the EKLF
enhancer in comparison to the non-specific binding to
non-related sequence (Figure 6C). In fact, the V5 tag
appears to work at least as good as streptavidin binding in
ChIP. When normalising to control cells expressing only
BirA, the V5 ChIP gives actually a slightly better enrich-
ment compared to the streptavidin ChIP (Figure 6C),
albeit with a slightly higher background binding to the
negative control sequence (Figure 6C and 6D). However,
we cannot exclude that the elution from the anti-V5 agar-
ose beads is more efficient than that from the M280
streptavidin beads.
Formaldehyde crosslinking affects the biotin-tag more 
than the V5 tag
Formaldehyde cross-linking as first introduced by Salo-
mon et al in Drosophila [32], has been widely used to study
the binding of proteins to DNA elements in intact cells.
Formaldehyde crosslinks proteins primarily through
lysine, glutamine, asparagine, arginine, tryptophan, tyro-
sine and histidine residues [1]. Biotinylation tagging takes
place through the addition of a biotin moiety to a single
lysine residue present in the peptide tag, thus rendering
this lysine residue unavailable for crosslinking, However,
the biotin molecule has two nitrogens in the ring structure
Comparison of sonication buffer with or without the addition of SDSFigure 4
Comparison of sonication buffer with or without the addition of SDS. Relative enrichment of EKLF sequences was 
calculated over chromatin from control cells.
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A) Chromatin from I/11 cells prepared with SDS in sonication bufferFigure 5
A) Chromatin from I/11 cells prepared with SDS in sonication buffer. Binding of RAD 21 and negative control (NC) 
to a β-globin site and the amylase gene (control for non-specific binding). B) Chromatin from I/11 cells prepared without SDS 
in sonication buffer. Binding of RAD 21 to specific site in β-globin locus is significantly improved in comparison to the result in 
panel A. C) Chromatin from I/11 cells prepared with SDS in sonication buffer. Binding of RAD 21 and negative control (NC) to 
a β-globin site and the necdin gene (control for non-specific binding). D) Chromatin from I/11 cells prepared without SDS in 
sonication buffer. Binding of RAD 21 to specific site in β-globin locus is significantly improved in comparison to result in panel 
C. Note that the binding of negative control (NC) to β-globin locus site is reduced.
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compared how the biotin tag or the V5 tag, a 14aa long tag
containing lysine and asparagine residues (GKPIPN-
PLLGLDST), are affected by formaldehyde crosslinking.
To this end, the extracts containing equal amounts of
GATA-1-V5-bio (see input lanes 1 and 4 in figure 7B, top
panel) were bound under identical conditions. Input,
bound and unbound fractions were loaded on an SDS-
PAGE gel and the western blots were detected with an anti
GATA-1 (N6) antibody followed by detection with
streptavidin-HRP. The results showed that the binding of
crosslinked material to the M280 Dynabeads was good
but less efficient compared to non-crosslinked protein
extract, since there was more GATA-V5-bio found in
unbound fraction (compare the amounts of GATA-1 in
lane 2 and lane 5 of unbound fractions 7B, top panel). In
addition, anti-GATA-1 antibody as well as streptavidin-
HRP detection (Fig. 7B, both panels) showed that there
was less GATA-1-V5-bio bound to the M280 Dynabeads
in cross-linked extract pull-down than in non-crosslinked
material (compare lanes 3 with 6 in Figure 7B, both pan-
els). These results would be expected considering that
some of the biotin tagged GATA-1 protein would be inac-
cessible for binding by M280-streptavidin beads in the
crosslinked chromatin, as has also been observed with
epitope access by antibodies in ChIP.
We next tested how formaldehyde crosslinking affects
binding to anti-V5 agarose. The western blot data pre-
sented in Figure 7C suggest that crosslinked and non-
crosslinked material can be efficiently bound by anti-V5
beads (Figure 7C top panel, compare lanes 2 with 3 and 5
with 6). The data suggest that the efficiency of binding of
crosslinked chromatin using the V5 tag is higher than that
of streptavidin ChIP (compare lanes 2, 3 of Figure 7C top
panel with lanes 5, 6 of Figure 7B top panel). However,
efficient recovery of chromatin from the V5 beads relies
on efficient elution with the V5 peptide. In addition, in
other cases we have not seen this difference (E. Soler, C.
Andrieu, unpublished observations) suggesting that the
structure of the target protein may also have an influence.
Discussion
We describe optimised conditions for the application of
streptavidin-ChIP using crosslinked chromatin from cells
expressing a biotin-tagged transcription factor. We show
that pre-clearing chromatin and blocking streptavidin
beads with fish skin gelatin reduces the background bind-
ing. In addition, avoiding SDS in the sonication buffer
appears to increase enrichment for bio-GATA-1 binding to
specific DNA sequences. We also compared streptavidin-
ChIP to antibody ChIP using two different anti-GATA-1
antibodies and showed the former to be more efficient.
The real difference in efficiencies between streptavidin-
ChIP and antibody ChIP is even bigger because the anti-
GATA-1 antibodies precipitate both the tagged and endog-
enous GATA-1, whereas streptavidin binds only tagged
GATA-1. This means that the enrichments obtained with
antibodies should be hypothetically approximately twice
as high as with affinity tags pull-downs. The same applies
for the efficiency of V5 ChIP, since, as mentioned above,
the relative levels of bio-V5- tagged GATA-1 and endog-
enous GATA-1 in the extract used in this experiment are
similar (Figure 6B). Thus, the results obtained with anti-
GATA-1 antibodies are an overestimate when compared
to the tag-based ChIPs described here.
A potential drawback of biotinylation tagging in streptavi-
din ChIP is related to previous reports of histones being
naturally biotinylated [33]. Though it remains unknown
what proportion of histones is biotinylated in vivo, the
fact that previous studies have shown nuclear biotin to
account for less than 1% of total cellular biotin [33,34]
suggests that it is very little. In addition, we have per-
A) Schematic representation of the C-terminally biotin-V5-tagged GATA-1Figure 6 (see previous page)
A) Schematic representation of the C-terminally biotin-V5-tagged GATA-1. NZF and CZF: N-terminal and C-ter-
minal zinc fingers, respectively. V5 and biotin (BIO) tags are not drawn to scale. B) Western blot detected with anti-GATA-1 
N6 antibody showing the relative amounts of biotin-V5-GATA-1 and endogenous GATA-1 in the cells used for ChIP. C) Com-
parison of V5, M280 and two different anti-GATA-1 antibodies, N6 and M20, tested for the binding of GATA-1 to the EKLF 
promoter. The enrichment is calculated over a BirA-only transfected control or over IgG negative control, respectively. V5 
ChIP gives the highest yield in the EKLF enhancer and promoter elements, streptavidin ChIP with M280 Dynabeads gives com-
parable yield in the upstream enhancer element as M20 anti-GATA-1 antibody. The M20 antibody can enrich for more GATA-
1 bound to the EKLF promoter than the M280 Dynabeads. The N6 antibody precipitates the least amount of GATA-1 bound 
to EKLF promoter elements. D) Comparison of V5, M280 and two different anti-GATA-1 antibodies N6 and M20, tested for 
the binding of GATA-1 to the EKLF promoter. Enrichment of the specific binding to EKLF promoter and enhancer was calcu-
lated over the negative primer set (-1.35 kb element in EKLF promoter). V5 agarose and M280 Dynabeads bring down compa-
rable amounts of GATA-1 bound to EKLF enhancer and promoter sequences. The M20 antibody enriches the most for GATA-
1 bound to the EKLF upstream enhancer, though this also included sequences in vivo bound by endogenous GATA-1 protein 
which can not be bound by M280 or anti-V5 beads. Rat and goat IgGs as well as BirA control show similarly low enrichments 
of specific primer sets.Page 10 of 14
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and, whereas we find histones co-purifying with biotin
tagged transcription factors, they do not represent any sig-
nificant proportion of the background, nor did we notice
an increase of histone peptides upon expression of BirA in
cells [7]. Similarly, the purification of a histone variant
protein complex by biotinylation tagging and streptavidin
purification showed negligible histone binding [35].
Lastly, biotinylation tagging has been employed in ChIP-
on-chip approaches of transcription factors and of the his-
tone H3.3 variant, again with no evidence of background
due to endogenous histone biotinylation [14,36]. Taken
together, this evidence suggests that any background due
to histone biotinylation is likely to be very low. In fact,
one of the advantages of employing biotinylation tagging
of different factors with streptavidin ChIP is that back-
ground will be the same in all cases, whereas different
antibodies present with different backgrounds.
We also provide evidence that a tandem affinity tag com-
posed of the biotin tag and the V5 epitope tag works very
efficiently in ChIP. The biotin tag binding is fast and very
tight, while the binding to V5 epitope is reversible (bound
material can be eluted from the beads using V5 peptide),
thus each tag can be used to advantage. On the basis of
this evidence, we propose a scheme whereby optimal
binding of chromatin, under the conditions described
here, first by anti-V5 agarose, followed by elution using V5
peptide and re-binding by streptavidin beads, followed by
elution/reversal of crosslinks provides a convenient and
rapid purification method. Our preliminary ChIP-
sequencing data (E. de Boer, unpublished) show that
biotin and V5 tagging can both be very effectively used for
transcription factor target sequence mapping and that the
(very low) background seen in these experiments contains
mostly non-specific DNA fragments that can be easily dis-
tinguished from specific target sites.
Conclusion
The optimal conditions for streptavidin ChIP described
here and the use of biotin-V5 tandem affinity tagging of
transcription factors offers an easy, rapid and effective way
for comparative and functional studies of different tran-
scription complexes.
Methods
Cells and constructs
MEL cells were cultured as previously described [35]. Con-
structs and stably transfected cell lines were described pre-
viously [7]. I/11 cells were cultured as previously
described [37].
Chromatin crosslinking
Approximately 2 × 107 induced MEL cells were crosslinked
with 1% formaldehyde for 10 minutes at room tempera-
ture and processed for sonication essentially as described
in the Upstate (now Millipore) protocol http://www.mil
lipore.com/techpublications/tech1/mcproto407. Chro-
matin was sonicated on ice with a Sanyo Soniprep 150
sonicator at amplitude 6 using 10 cycles of 15 sec "on"
and 45 sec "off" to a DNA fragment size in the range of
300 to 800 nucleotides. The alternative "no SDS" sonica-
tion buffer is: 10 mM Tris, 1 mM EDTA and 0.5 mM EGTA.
All buffers were supplemented with Complete Protease
Inhibitor Cocktail (Roche). Aliquots of sonicated chroma-
tin of 10 × 106 cells were stored at -80°C.
Streptavidin ChIP
Chromatin pull-downs with streptavidin beads were car-
ried out overnight using 20 μl of streptavidin Dynabeads
M280 (Invitrogen) or 20 μl of UltraLink Immobilized
NeutrAvidin Protein (Pierce) per chromatin aliquot. For
streptavidin agarose (Sigma) or Streptavidin mutein
(Roche) chromatin pull-downs, 60 μl of agarose slurry or
beads were used per aliquot. All the beads/slurry were
blocked with 400 μg sonicated salmon sperm DNA for 1
h at 4°C. Pre-clearing of chromatin prior to binding to
M280 streptavidin beads was done using 20 μl of Protein
G Dynabeads (Invitrogen) preblocked with salmon sperm
DNA. Chromatin incubation with beads was carried out
in a total reaction volume of 1 mL supplemented with
Complete Protease Inhibitor, at 4°C overnight on a rotat-
ing wheel. After binding, beads were washed with 1 mL of
low salt, high salt, LiCl and TE (10 mM Tris-HCl pH 8.0,
A) Structure of the formaldehyde sensitive amino acids and sensitive groups in biotin (arrows)Figu e 7 (s e previous page)
A) Structure of the formaldehyde sensitive amino acids and sensitive groups in biotin (arrows). B) Western blot 
analysis of two binding experiments where non-crosslinked nuclear extracts (lanes 1, 2, 3) and formaldehyde crosslinked chro-
matin (lanes 4, 5, 6) were tested. Input and supernatant fractions (lanes 1 and 2, 4 and 5 respectively) represent 1% of total 
material, while bound lanes (3 and 6) represent 25% of total material. The biotin-V5-tagged GATA-1 was detected with N6 
anti-GATA-1 antibody (top panel). After stripping, the same membrane was incubated with streptavidin-HRP (lower panel). C) 
Western blot showing comparison of binding of two different extracts: crosslinked chromatin (lanes 1–3) and non-crosslinked 
nuclear extract (lanes 4–6) precipitated by anti-V5 agarose. The biotin-V5-tagged GATA-1 was detected with N6 anti-GATA-1 
antibody (top panel), stripped and re-probed with streptavidin-HRP (lower panel). Input and supernatant fractions (lanes 1 and 
3, 4 and 6 respectively) represent 1% of total material, while bound lanes (2 and 4) represent 50% of total material. Note that 
V5-tagged GATA-1 is completely depleted in both experiments as the supernatant lanes are empty.Page 12 of 14
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tional urea wash (5 M urea/2 M thiourea/1% TritonX100)
was carried out after LiCl buffer wash and before the TE
washes (see Results). After the washes, bound chromatin
was eluted by resuspending Neutravidin, Mutein, strepta-
vidin agarose and M280 beads in 500 μl 0.1 M sodium
carbonate, 1%SDS, 0.2 M NaCl elution buffer transferring
to a fresh tube and decrosslinking with shaking at 65°C
for at least 5 h. Thermal elution of chromatin from M280
Dynabeads was carried out by resuspending beads in 500
μl 95% formamide, 0.1 M sodium bicarbonate and boil-
ing at 95°C for 10 min. M280 Dynabeads were subse-
quently separated from the buffer using a magnetic rack.
Eluted chromatin was transferred to a fresh tube and
decrosslinking was carried out as described above.
Decrosslinked samples were deproteinized as described
by the Upstate protocol. DNA was recovered by phenol/
chloroform/isoamyl alcohol extraction and isopropanol
precipitation using 20 μg glycogen as carrier.
Antibody ChIP
GATA-1 ChIP has been previously described [8]. Anti-
GATA-1 antibodies used were N6 and M20 (Santa Cruz),
anti-RAD21 antibodies were ab992-50 (Abcam). Anti
GATA-1 antibody immunoprecipitates were eluted from
the beads by incubation in elution buffer (0.1 M sodium
carbonate, 1%SDS) twice for 15 minutes each at room
temperature. The V5 ChIP was carried out with V5 beads
(Sigma A7345). 60 μl of beads were spun and taken up in
1 ml PBS containing 200 μg sonicated salmon sperm DNA
and 1.5% fish skin gelatin (Sigma G7765) mixed for 1
hour RT and washed with PBS. Diluted chromatin was
taken up to 1 ml with Upstate ChIP dilution buffer and
bound overnight to the blocked V5 beads at 4°C on a
rotating wheel. Washing was carried out as described in
the Upstate protocol http://www.millipore.com/techpub
lications/tech1/mcproto407. Elution was done in 40 μl
HENG(10 mM HEPES-KOH pH 9.0, 1.5 mM MgCl2, 0.25
mM EDTA, 20% glycerol), 250 mM KCl, 0.3% NP40 and
0.5 mg/ml V5 peptide repeated 3 times 20 min each. Elu-
ates were pooled.
Blocking with Cold Sea Fish Skin Gelatin
A 45% Fish Skin gelatin (FGEL) stock solution (Sigma
G7765) was used to block beads at 0.5%, 1% or 2% final
concentrations together with sonicated salmon sperm
DNA by incubation for 1 h at room temperature. Where
indicated, FGEL was also added to chromatin and beads
to a 1% final concentration during overnight binding.
Real time PCR
This was done in an Opticon I (MJ Research) thermal
cycler using SYBR Green and Platinum Taq polymerase
(Invitrogen) as described previously [8]. Primers (listed in
Table 1) were designed using Primer Express 2.0 (PE
Applied Biosystems). For each experiment at least two
runs were done with each sample loaded in duplicate.
PCR conditions: 95°C for 10 min, 40 cycles of 30 sec at
95°C, 60 sec at 60°C, 15 sec at 75°C. Enrichment for a
specific DNA sequence was calculated using the compara-
tive CT method, as previously described [38]. The enrich-
ment of bound DNA over input is calculated using the
formula 2Ct(IP)-Ct(Ref). Enrichment over the negative primer
set or negative control chromatin from MEL cells express-
ing BirA only was subsequently calculated by dividing.
Nuclear extracts and immunoblotting
These were done as previously described [7].
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